HCA Says Florida Medicaid Approval Cushions 2Q

Dow Jones
07/14

A regulatory win in Florida is providing HCA Healthcare with a timely offset to its payer mix pressures. The company recognized approximately $400 million in incremental net benefit from Medicaid Supplemental Payment Programs during the second quarter, the company said. The bulk of that stems from Florida's state-directed payment program, which the Centers for Medicare and Medicaid Services approved during the quarter. The benefit covers the period from Oct. 1, 2024, through June 30, 2026. HCA now expects Medicaid supplemental programs to contribute $300 million to $500 million for full-year 2026, compared with an earlier estimate of a $50 million to $250 million drag

 

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

 

(END) Dow Jones Newswires

July 14, 2026 08:45 ET (12:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10